J0578 Injection, buprenorphine extended release (brixadi), greater than 7 days and up to 28 days of therapy
Short descriptor: Inj brixadi, more than 7 day
Look up J0578 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.
J0578 is the HCPCS Level II code for Injection, buprenorphine extended release (brixadi), greater than 7 days and up to 28 days of therapy (2026). It belongs to Section J — Drugs Administered Other Than Oral Method. Under Medicare, its coverage status is: Carrier judgment. Part B pricing methodology: Drugs.
Classification & CMS Attributes
- Medicare Coverage
- Carrier judgment (code C)
- Part B Pricing
- Drugs (indicator 51)
- Type of Service
- Medical care
- Effective Date
- 2024-04-01
- 2026 Maintenance
- No change this year
Drug Details
- Drug / Substance
- buprenorphine extended release, greater than 7 days and up to 28 days of therapy
- Route
- Injection
See the full HCPCS Table of Drugs (J-codes).
References
Cite This Page
Reference J0578 with the canonical source and edition:
J0578 — Injection, buprenorphine extended release (brixadi), greater than 7 days and up to 28 days of therapy. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/J0578
Canonical URL: https://icd10codingpro.com/hcpcs-codes/J0578